UroGen Pharma
URGN
URGN
158 hedge funds and large institutions have $891M invested in UroGen Pharma in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 149 → 158 (+9)
4% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 45
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
158
Holding in Top 10
3
Calls
$36.2M
Puts
$11.1M
Top Buyers
| 1 | +$84.1M | |
| 2 | +$17.5M | |
| 3 | +$17.2M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$14.3M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$13.7M |
Top Sellers
| 1 | -$30M | |
| 2 | -$11.4M | |
| 3 | -$9.19M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$8.88M |
| 5 |
Citigroup
New York
|
-$7.59M |
